4-Piperidinecarboxylic acid → 4'-(4-(2-Methoxy-phenylsulfanyl)-3-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-(1,2')bipyridinyl-4-carboxylic acid

HRID 1005811

Reaktionsgleichung

Reaktionsgleichung von HRID 1005811
Cl[C:2]1[CH:7]=[C:6]([C:8]2[CH:13]=[CH:12][C:11]([S:14][C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][C:16]=3[O:21][CH3:22])=[C:10]([C:23]([F:26])([F:25])[F:24])[CH:9]=2)[CH:5]=[CH:4][N:3]=1.OC1CCNC1.[NH:33]1[CH2:41][CH2:40][CH:36]([C:37]([OH:39])=[O:38])[CH2:35][CH2:34]1>>[CH3:22][O:21][C:16]1[CH:17]=[CH:18][CH:19]=[CH:20][C:15]=1[S:14][C:11]1[CH:12]=[CH:13][C:8]([C:6]2[CH:5]=[CH:4][N:3]=[C:2]([N:33]3[CH2:41][CH2:40][CH:36]([C:37]([OH:39])=[O:38])[CH2:35][CH2:34]3)[CH:7]=2)=[CH:9][C:10]=1[C:23]([F:26])([F:25])[F:24]

Komponenten

4

Versuchsvorschrift

The title compound was prepared according to the procedures of Example 38E, substituting compound 76 with compound 96 (0.039 g, 0.0985 mmol) and 3-hydroxypyrrolidine with isonipecotic acid. A yellow solid 106 was obtained (0.0225 g, 47%). 1H-NMR (CDCl3, 400 MHz) δ 1.90-1.99 (m, 2H), 2.09-2.16 (m, 2H), 2.68-2.77 (m, 1H), 3.43-3.50 (m, 2H), 3.83 (s, 3H), 4.14-4.20 (m, 2H), 6.95 (d, J=6.2 Hz, 1H), 6.99-7.05 (m, 3H), 7.06 (d, J=8.4 Hz, 1H), 7.45-7.52 (m, 3H), 7.84 (s, 1H), 8.20 (d, J=6.6 Hz, 1H); MS (APCI) m/z 489 (M+H)+.

Quellen und Nachweise

ORD-Eintrag
ord-87b6ea9670b34e1582afad8557f8e94f
Quelldatensatz
uspto-grants-2004_09
Patentnummer
US06787542B2

Verknüpfte Notizen

Wird geladen…